STARD10
START domain-containing protein 10
Also known as: CGI-52, NY-CO-28, PCTP2, SDCCAG28, STA10_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y365
- Gene
- STARD10
- Ensembl
- ENSG00000214530
- Chromosome
- 11
- Canonical length
- 291 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Predicted to enable lipid binding activity. Predicted to be involved in lipid transport. Predicted to act upstream of or within bile acid secretion and positive regulation of peroxisome proliferator activated receptor signaling pathway. Located in cytosol. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
291 residues, UniProt reviewed canonical sequence.
>Q9Y365|STARD10
1 MEKLAASTEP QGPRPVLGRE SVQVPDDQDF RSFRSECEAE VGWNLTYSRA GVSVWVQAVE
61 MDRTLHKIKC RMECCDVPAE TLYDVLHDIE YRKKWDSNVI ETFDIARLTV NADVGYYSWR
121 CPKPLKNRDV ITLRSWLPMG ADYIIMNYSV KHPKYPPRKD LVRAVSIQTG YLIQSTGPKS
181 CVITYLAQVD PKGSLPKWVV NKSSQFLAPK AMKKMYKACL KYPEWKQKHL PHFKPWLHPE
241 QSPLPSLALS ELSVQHADSL ENIDESAVAE SREERMGGAG GEGSDDDTSL TLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STARD10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 710 nTPM
Expression across tissuesHPA
Tissue
- liver: 710 nTPM
- stomach: 257 nTPM
- pancreas: 206 nTPM
- testis: 179 nTPM
- adrenal gland: 178 nTPM
- rectum: 176 nTPM
Single-cell type
- late spermatids: 704 nCPM
- parietal cells: 226 nCPM
- early spermatids: 114 nCPM
- gastric chief cells: 108 nCPM
- late primary spermatocytes: 84 nCPM
- mucous neck cells: 68 nCPM
Immune cell
- neutrophil: 21 nTPM
- eosinophil: 16 nTPM
- basophil: 12 nTPM
- NK-cell: 7.4 nTPM
- memory B-cell: 4.1 nTPM
- classical monocyte: 2.4 nTPM
Brain region
- choroid plexus: 55 nTPM
- cerebellum: 50 nTPM
- pons: 48 nTPM
- basal ganglia: 46 nTPM
- cerebral cortex: 46 nTPM
- medulla oblongata: 43 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.34
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STARD10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STARD10 as an antibody target. Whether an autoantibody or antibody against STARD10 could matter depends on whether native STARD10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STARD10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STARD10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...